Evidence map›Paper›PMID 32582652›Full record

ArticleFrontiers in bioengineering and biotechnology2020

R-Spondin 1 (RSPO1) Increases Mouse Intestinal Organoid Unit Size and Survival

Gabriel Levin, Samuel M Zuber, Anthony I Squillaro, Mari Cleide Sogayar, Tracy C Grikscheit, Ana Claudia O Carreira

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Gabriel LevinCell and Molecular Therapy Center (NUCEL), School of Medicine, University of São Paulo, São Paulo, Brazil.
Samuel M ZuberDevelopmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Anthony I SquillaroDevelopmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Mari Cleide SogayarCell and Molecular Therapy Center (NUCEL), School of Medicine, University of São Paulo, São Paulo, Brazil.
Tracy C GrikscheitDevelopmental Biology and Regenerative Medicine Program, Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA, United States.
Ana Claudia O CarreiraCell and Molecular Therapy Center (NUCEL), School of Medicine, University of São Paulo, São Paulo, Brazil.
Children's Hospital of Los Angeles · USUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

3D cultureorganoid unit (OU)recombinant human R-Spondin 1 (rhRSPO1)scaffoldstem cellstissue-engineered small intestine (TESI)tissue engineering

Identifiers

PMID32582652
PMCPMC7295003
OpenAlexW3026403544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.